| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.087 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.1 | 0.5 |